Skip to search formSkip to main contentSkip to account menu

peginesatide

Known as: Erythropoiesis-Stimulating Agent (ESA) 
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

AF-37702
Erythropoiesis-stimulating Agent [EPC]Erythropoietin

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Detection of peginesatide by SDS-PAGE
Thanks to the valuable collaboration of Affymax that was initiated by WADA, two different methods, ELISA and SDS electrophoresis… 
2013
2013
Newborns sequenced at NIH
volume 31 NumBeR 11 NovemBeR 2013 nature biotechnology subunits. Under hypoxic conditions, as HIF-PH requires oxygen as a… 
2013
2013
On Peginesatide and Anemia Treatment in CKD
Anemia often occurs in patients with advanced chronic kidney disease (CKD) as a result of erythropoietin deficiency and thus is… 
2013
2013
Peginesatide for anemia in chronic kidney disease.
2013
2013
Peginesatide for Renal Anemia
Anemia impairs the quality of life in patients with chronic kidney disease. Erythropoietin is effective in raising hemoglobin… 
2012
2012
New ESA to be available for dialysis patients.
Peginesatide, an erythropoiesis-stimulating agent (ESA) intended for once-a-month treatment of anemia due to chronic kidney… 
2011
2011
33 Safety and Efficacy of Peginesatide for Treatment of Anemia in Hemodialysis Patients Previously on Epoetin Alfa or Beta
SAFETY AND EFFICACY OF PEGINESATIDE FOR TREATMENT OF ANEMIA IN HEMODIALYSIS PATIENTS PREVIOUSLY ON EPOETIN ALFA OR BETA Anatole… 
2010
2010
An exploratory analysis of transfusion risk when initiating darbepoetin alfa (DA) therapy at baseline hemoglobin (Hb) < 9 g/dl vs 9 to < 10 g/dl versus ≥ 10 g/dl in patients (pts) with chemotherapy…
9077 Background: DA is an erythropoiesis-stimulating agent (ESA) approved in the US and EU to treat CIA based on controlled… 
2010
2010
How to detect blood doping with subcutaneous or intravenous injection of C
Purpose: C.E.R.A., a continuous erythropoietin receptor activator, is a new third-generation erythropoiesis-stimulating agent… 
2008
2008
TRANSFUSION IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA
Recent studies questioning the safety of erythropoiesis-stimulating agent (ESA) therapy and the resultant cautionary US Food and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)